RxDoctor Payments Data

Ashley McGuffin, APRN

Family · Bainbridge, INNPI 1679158216

Payments from drug & device makers

$1,249in general payments, 2019–2025

Across 67 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$235
  • AbbVie$208
  • Bayer$147
  • Novo Nordisk$147
  • AstraZeneca$102
  • GSK$101
  • plus $309 from 8 others

What the payments were for

  • Food & beverage$1,249100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,249 in reported general payments places this provider in the 70th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$5,430
Medicare patients
49
Services billed
569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide22$35,893
OzempicSemaglutide26$27,080
MounjaroTirzepatide18$25,941
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$21,022
EliquisApixaban19$16,392
SymbicortBudesonide/Formoterol Fumarate12$5,458
Albuterol Sulfate HfaAlbuterol Sulfate60$1,980
Atorvastatin Calcium137$728
Levothyroxine Sodium59$502
Omeprazole38$349
Mirtazapine21$345
Metoprolol Succinate42$296
Bupropion XlBupropion Hcl22$284
Gabapentin40$272
Rosuvastatin Calcium36$267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$235$61,83440 claims
Novo NordiskOzempic$147$27,08026 claims
GSKTrelegy Ellipta$101$21,02213 claims
AstraZenecaSymbicort$102$5,45812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,392 family providers in Indiana.

Other family in Bainbridge

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →